Skip to main content
Top

Clinical and Translational Oncology

Issue 4/2002

Content (14 Articles)

Revisiones

The molecular biology of topoisomerase IIα and its importance in the acquisition of multidrug resistance in cancer

Víctor Bautista de Lucio, Vicente Madrid Marina, Raúl Barrera Rodríguez

Revisiones

Tumour inmunology: How close to the target?

Yvelise Barrios del Pino, Fernando Díaz-Espada Lorenzo, Rafael Cabrera Marín

Originales

Second-line chemotherapy with weekly paclitaxel in patients with advanced non-small-cell lung cancer

Luis Ángel León Mateos, Juan Fernando Cueva Bañuelos, María Teresa Curiel García, María Calvo Rodríguez, Begoña Graña Suárez, Sonia Candamio Folgar, Francisco Javier Barón Duarte, Rafael López López

Originales

Hemipelvectomía interna

Alfredo Die Goyanes, Rafael Beni Pérez, Javier Die Trill

Originales

Angiosarcoma de la mama: informe de 5 casos

Ángel Herrera-Gómez, Guillermo Flores-Flores, Martín Granados-García, Kuauhyama Luna-Ortiz, Gonzalo Montalvo-Esquivel, María Teresa Ramírez-Ugalde

Originales Breves

Potential complications of the growing teratoma syndrome in patients with advanced germ-cell tumors: description of three cases

Jorge Aparicio, Regina Gironés, José Alejandro Pérez-Fidalgo, Verónica Calderero, Roberto Díaz, Joaquín Montalar

Notas Clínicas

Deletion 6q and +X in one primary central nervous system lymphoma (PCNSL) arising in a patient without immune defects

María Josefa Bello González, José María de Campos Gutiérrez, María Elena Kusak Lambea, José Luis Sarasa Corral, Juan Antonio Rey Herranz

Notas clínicas

Pancreatitis aguda inducida por L-asparraginasa

Francisco Valverde Moreno, Celia Gil López, José Luis Ruibal Francisco, Santiago Rueda Esteban, María Luisa Jiménez Álamo, Carlos Maluenda Carrillo

Sección docente

Radiotherapy and tumour hypoxia

Albert Biete Solá, Angels Rovirosa Casino

Correspondencia

Quimioterapia en cáncer avanzado de cabeza y cuello: Aprender a pasar página

A. Villar Rodríguez, Juan A. Santos Miranda, Carmen González San Segundo, Álvaro Sanz Rubiales

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine